文献速递淋巴瘤

妊娠期淋巴瘤的临床特征、管理与结局:澳大利亚亚淋淋巴瘤联盟多中心研究

The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance.
PubMed 文献 · Br J Haematol · 2023-03-07

该多中心回顾性观察研究纳入2009年1月至2020年12月在澳大利亚和新西兰16个中心诊断的73例妊娠期淋巴瘤患者,其中产前诊断41例、产后诊断32例。最常见诊断为霍奇金淋巴瘤40例、弥漫大B细胞淋巴瘤11例和原发纵隔B细胞淋巴瘤6例。中位随访2.37年,霍奇金淋巴瘤患者2年和5年总生存率分别为91%和82%,弥漫大B细胞淋巴瘤联合原发纵隔B细胞淋巴瘤组2年总生存率为92%。

要点

  • 产前诊断组64%成功接受标准化治愈性化疗方案。
  • 霍奇金淋巴瘤2年和5年总生存率分别为91%和82%。
  • 关于未来生育力和终止妊娠的咨询不理想,分期方法缺乏标准化。

核心结论

  • 研究呈现了一个反映当代实践的大规模妊娠期淋巴瘤多中心队列,并确定了需要持续研究的领域。

研究设计与样本

  • 多中心回顾性观察研究,纳入2009年1月至2020年12月在澳大利亚和新西兰16个中心诊断的患者。
  • 共纳入73例患者,产前诊断41例(产前队列),产后诊断32例(产后队列)。
  • 纳入妊娠期间或分娩后前12个月内诊断的病例。

主要发现

  • 最常见诊断为霍奇金淋巴瘤40例、弥漫大B细胞淋巴瘤11例和原发纵隔B细胞淋巴瘤6例。
  • 中位随访2.37年,霍奇金淋巴瘤患者2年和5年总生存率分别为91%和82%。
  • 弥漫大B细胞淋巴瘤联合原发纵隔B细胞淋巴瘤组2年总生存率为92%。
  • 产前队列中64%的女性成功接受标准化治愈性化疗方案。
  • 新生儿结局总体良好。

关键数值与推荐

  • 霍奇金淋巴瘤患者2年总生存率91%,5年总生存率82%。
  • 弥漫大B细胞淋巴瘤联合原发纵隔B细胞淋巴瘤组2年总生存率92%。
  • 产前队列中64%成功接受标准化治愈性化疗方案。

临床怎么用

  • 关于未来生育力和终止妊娠的咨询不理想。
  • 分期方法缺乏标准化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lymphoma in pregnancy (LIP) presents unique clinical, social and ethical challenges; however, the evidence regarding this clinical scenario is limited. We conducted a multicentre retrospective observational study reporting on the features, management, and outcomes of LIP in patients diagnosed between January 2009 and December 2020 at 16 sites in Australia and New Zealand for the first time. We included diagnoses occurring either during pregnancy or within the first 12 months following delivery. A total of 73 patients were included, 41 diagnosed antenatally (AN cohort) and 32 postnatally (PN cohort). The most common diagnoses were Hodgkin lymphoma (HL; 40 patients), diffuse large B-cell lymphoma (DLBCL; 11) and primary mediastinal B-cell lymphoma (PMBCL; six). At a median follow up of 2.37 years, the 2- and 5-year overall survival (OS) for patients with HL were 91% and 82%. For the combined DLBCL and PMBCL group, the 2-year OS was 92%. Standard curative chemotherapy regimens were successfully delivered to 64% of women in the AN cohort; however, counselling regarding future fertility and termination of pregnancy were suboptimal, and a standardised approach to staging lacking. Neonatal outcomes were generally favourable. We present a large multicentre cohort of LIP reflecting contemporary practice and identify areas in need of ongoing research.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Di Ciaccio PR, Mills G, Shipton MJ, et al. The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance. Br J Haematol. 2023. PMID: 36880558. doi:10.1111/bjh.18727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。